17β-hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in Denmark.

被引:0
|
作者
Collin, Lindsay Jane [1 ]
Kjaersgaard, Anders [2 ]
Ahern, Thomas P. [3 ]
Goodman, Michael [4 ]
McCullough, Lauren E. [4 ]
Waller, Lance A. [4 ]
Christensen, Kristina B. [5 ]
Damkier, Per [6 ]
Hamilton-Dutoit, Stephen J. [5 ]
Lauridsen, Kristina [5 ]
Chistiansen, Peer M. [5 ]
Ejlertsen, Bent [7 ]
Sorensen, Henrik Toft [2 ]
Cronin-Fenton, Deirdre [2 ]
Lash, Timothy L. [4 ]
机构
[1] Huntsman Canc Inst, Salt Lake City, UT USA
[2] Aarhus Univ, Aarhus, Denmark
[3] Univ Vermont, Burlington, VT USA
[4] Emory Univ, Atlanta, GA 30322 USA
[5] Aarhus Univ Hosp, Aarhus, Denmark
[6] Odense Univ Hosp, Odense, Denmark
[7] Danish Breast Canc Grp, Copenhagen, Denmark
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
757
引用
收藏
页数:2
相关论文
共 50 条
  • [1] 17β-Hydroxysteroid dehydrogenase type 1 as predictor of tamoxifen response in premenopausal breast cancer
    Kallstrom, Ann-Christine
    Salme, Rebecka
    Ryden, Lisa
    Nordenskjold, Bo
    Jonsson, Per-Ebbe
    Stal, Olle
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (05) : 892 - 900
  • [2] Abnormal expression of 17β-hydroxysteroid dehydrogenases in breast cancer predicts late recurrence
    Gunnarsson, C
    Olsson, BM
    Stål, O
    CANCER RESEARCH, 2001, 61 (23) : 8448 - 8451
  • [3] Possible deleterious effect of tamoxifen in premenopausal women with locoregional recurrence of breast cancer
    Borner, MM
    Bacchi, M
    Castiglione, M
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (12) : 2173 - 2176
  • [4] 17(ss)-hydroxysteroid dehydrogenase type 1 is a predictive factor in premenopausal hormone receptor positive breast cancer treated with tamoxifen
    Kallstrom, A-C
    Salme, R.
    Ryden, L.
    Gunnarsson, C.
    Nordenskjold, B.
    Stal, O.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S84 - S85
  • [5] Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal Women
    Collin, Lindsay J.
    Cronin-Fenton, Deirdre P.
    Ahern, Thomas P.
    Goodman, Michael
    McCullough, Lauren E.
    Waller, Lance A.
    Kjaersgaard, Anders
    Damkier, Per
    Christiansen, Peer M.
    Ejlertsen, Bent
    Jensen, Maj-Britt
    Sorensen, Henrik Toft
    Lash, Timothy L.
    CLINICAL CANCER RESEARCH, 2021, 27 (05) : 1421 - 1428
  • [6] The role of 17β-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells
    Newman, SP
    Ireson, CR
    Tutill, HJ
    Day, JM
    Parsons, MFC
    Leese, MP
    Potter, BVL
    Reed, MJ
    Purohit, A
    CANCER RESEARCH, 2006, 66 (01) : 324 - 330
  • [7] Association of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancer
    Sun, L-M
    Chen, H-J
    Liang, J-A
    Li, T-C
    Kao, C-H
    BRITISH JOURNAL OF CANCER, 2014, 111 (09) : 1836 - 1842
  • [8] Association of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancer
    L-M Sun
    H-J Chen
    J-A Liang
    T-C Li
    C-H Kao
    British Journal of Cancer, 2014, 111 : 1836 - 1842
  • [9] Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women
    Sillanpää, P
    Kataja, V
    Eskelinen, M
    Kosma, VM
    Uusitupa, M
    Vainio, H
    Mitrunen, K
    Hirvonen, A
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (10): : 749 - 752
  • [10] Fear of Cancer Recurrence among Aboriginal and Torres Strait Islander Women Diagnosed with Breast Cancer
    Butler, Tamara
    Smith, Ben
    Pilatti, Kirsten
    Brown, Bena
    Anderson, Kate
    Morris, Bronwyn
    Garvey, Gail
    CURRENT ONCOLOGY, 2023, 30 (03) : 2900 - 2915